re; $PMCB "One of the untold stories behind PharmaCyte Biotech's success is that the formation and implementation of its International Diabetes Consortium has already resulted in unique and unprecedented collaboration on diabetes research which should lead to expedited clinical trials.
The 16-member group, which boasts top tier scientists and doctors in the field of diabetes research and treatment, has members concurrently leading PharmaCyte Biotech-related diabetes research projects in more than half a dozen universities in Europe and Asia."